Guadalupe Hayes-Mota is Director of the Bioethics Program at the Markkula Center for Applied Ethics at 糖心破解版, where he leads work at the intersection of artificial intelligence, biotechnology, health care ethics, and health equity. He teaches applied health care ethics through the Health Care Ethics Internship.
His career has been shaped by his experience as a child diagnosed with a rare disease in Mexico, where limited access to life-saving medicine led him to move to the United States in search of health care. That early experience has informed his lifelong commitment to improving access to medicines and building more ethical health systems.
Hayes-Mota is the founder and former CEO of Healr Solutions, an AI-powered company focused on optimizing global drug distribution and manufacturing. Under his leadership, the company scaled its work across 43 countries before being acquired. He previously held senior executive roles in global biopharmaceutical supply chain and operations at Biogen, Amgen, and GSK, including Chief Supply Chain Officer roles, where he helped oversee complex systems responsible for delivering life-saving medicines across 113 countries and territories. Earlier in his career, he helped lead one of the largest free health care systems in the United States at UCLA Health.
In public policy, Hayes-Mota contributed to health policy work related to the Affordable Care Act through the RAND Corporation. He currently serves on the NIH Cures Acceleration Network Review Board, appointed by the U.S. Secretary of Health and Human Services, and has contributed expert guidance to global health and technology initiatives involving the European Commission, OpenAI, and the World Economic Forum.
An accomplished educator, Hayes-Mota previously served as a Senior Lecturer and Practitioner-in-Residence at the Massachusetts Institute of Technology, where he designed and taught courses on the ethics of biopharmaceuticals. His teaching has focused on the ethical complexities of drug development, patient access, health innovation, and responsible leadership in biotechnology.
He has served in governance and advisory roles with organizations including Fenway Health, Save One Life, the MIT Alumni Association, the NIH, and the Commonwealth of Massachusetts. His work and commentary have appeared in Forbes, Fast Company, STAT, The New York Times, The Boston Globe, Inc. Magazine, NPR, MIT Technology Review, Business Insider, and The Bridge, the journal of the National Academy of Engineering.
Hayes-Mota has been recognized by Business Insider as one of six powerful LGBTQ+ executives to have on corporate boards and by PharmaVoice as one of the 100 Most Influential People in the life sciences industry.
He holds dual bachelor’s degrees in chemistry and literature, a master of science in AI engineering systems, and an MBA from MIT, as well as a master of public administration from Harvard University. He is currently pursuing a Doctorate in AI and Machine Learning at George Washington University, with research focused on AI in drug development and health care.
Courses
ELSJ 198: Applied Ethics Internship in Health Care
Selected Publications
“.” Forbes. May 12, 2026.
“.” Forbes. November 19, 2025.
“s.” Fast Company. October 15, 2024.
“.” Forbes. September 26, 2024.
“” The Bridge, 53(4), 27–31. National Academy of Engineering.
“” Forbes. July 10, 2023.
“” STAT. July 26, 2021.